Reulay

Reulay is a private digital therapeutics and mental performance company developing an AI-driven platform for personalized mental wellbeing. The company delivers on-demand interventions across mobile, web, and immersive VR/AR/XR formats to help reduce stress, anxiety, burnout, and emotional distress while improving focus and performance. Its offering is positioned for business, healthcare, sports, and individual users rather than as a traditional drug-development biotech. Reulay highlights a brain science- and machine learning-based personalization approach and cites research, including a Mayo Clinic study, supporting improvements in wellbeing and reductions in anxiety-related symptoms. The company appears to be commercially active with live product offerings and enterprise deployments.